US Patent Issued to 60 DEGREES PHARMACEUTICALS on July 28 for "Methods for the treatment and prevention of lung infections caused by gram-positive bacteria, fungus, or virus by administration of tafenoquine" (District Of Columbia Inventor)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,107, issued on July 28, was assigned to 60 DEGREES PHARMACEUTICALS INC. (Washington).

"Methods for the treatment and prevention of lung infections caused by gram-positive bacteria, fungus, or virus by administration of tafenoquine" was invented by Geoffrey S. Dow (Washington).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and composition for treating or preventing a lung infection, or related symptoms, caused by a bacterium, fungus, and/or virus using an effective amount of tafenoquine are disclosed. Methods and compositions for treating or preventing a lung infection in a human that is infected with SARS-CoV-2 using tafenoquine are disclosed...